Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy
Immunotherapy has revolutionized the treatment of many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has not been touched. GBM tumors are sometimes called “cold” -; that is, the immune system has difficulty detecting and targeting them, allowing tumor cells to continue to grow uncontrollably, even with …